Blog

Aren Karapetyan: Latest findings from Ontario revealing dynamic shifts in the management of Stage I NSCLC

Photo taken from www.thegreenjournal.com

May 3, 2024, 22:20

Aren Karapetyan: Latest findings from Ontario revealing dynamic shifts in the management of Stage I NSCLC

Aren Karapetyan, Medical Resident at Yerevan State Medical University named after Mkhitar Heratsi and Secretary at the shared a post on LinkedIn:

“Delve into the latest findings from Ontario, Canada, revealing dynamic shifts in the management of Stage I NSCLC from 2010 to 2019. Stereotactic Ablative Body Radiotherapy, particularly Stereotactic Ablative Body Radiotherapy (SABR), is becoming increasingly popular, with more patients opting for it and experiencing better survival rates. Meanwhile, surgical methods are on the decline, indicating a significant change in how lung cancer is treated.”

Additional information.
Source: Aren Karapetyan/LinkedIn

Aren Karapetyan Canada cancer dynamic shifts lung cancer treatment management trends Medical Research non small cell lung cancer OncoDaily Oncology Ontario SABR stage I NSCLC stereotactic ablative body radiotherapy surgical methods survival rates

April is Head and Neck Cancer Awareness Month

Is Cancer Hereditary? Myths and Facts about Cancer Genetics

Neuroendocrine Lung Tumors: Types, Symptoms, Diagnosis, Treatment and 2025 updates

Cancer Center Near Me: Dana-Farber Cancer Institute

FDA Approves Nivolumab and Ipilimumab for First-Line Treatment of Unresectable Hepatocellular Carcinoma Based on CheckMate-9DW Trial